Literature DB >> 25566345

Effect of intra-arterial injection of lidocaine and methyl-prednisolone into middle meningeal artery on intractable headaches.

Adnan I Qureshi1, Mushtaq H Qureshi1, Asif A Khan1, M Fareed K Suri1.   

Abstract

The present report describes the effect of intra-arterial injection of a dose of 40 mg lidocaine and 20 mg methylprednisolone into the middle meningeal artery of two patients suffering from severe headaches. The effect of injection of lidocaine and methylprednisolone was short lasting with effect manifesting within 5 min and lasting 5-8 h after injection. Both patients reported improvement in headache intensity after 24 h post-procedure. Intra-arterial injection of lidocaine and methylprednisolone may represent another treatment strategy for headaches not responsive to standard treatment.

Entities:  

Year:  2014        PMID: 25566345      PMCID: PMC4280869     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  20 in total

Review 1.  Why use placebos in clinical trials? A narrative review of the methodological literature.

Authors:  A J Vickers; A J de Craen
Journal:  J Clin Epidemiol       Date:  2000-02       Impact factor: 6.437

Review 2.  Dangerous extracranial-intracranial anastomoses and supply to the cranial nerves: vessels the neurointerventionalist needs to know.

Authors:  S Geibprasert; S Pongpech; D Armstrong; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2009-03-11       Impact factor: 3.825

3.  Microvascularization of the intracranial dura mater.

Authors:  J Roland; C Bernard; S Bracard; A Czorny; J Floquet; J M Race; P Forlodou; L Picard
Journal:  Surg Radiol Anat       Date:  1987       Impact factor: 1.246

4.  Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.

Authors:  Dawn C Buse; Elizabeth W Loder; Jennifer A Gorman; Walter F Stewart; Michael L Reed; Kristina M Fanning; Daniel Serrano; Richard B Lipton
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

5.  An endovascular procedure-specific neurological examination scheme for intraprocedural monitoring in awake patients.

Authors:  Adnan I Qureshi
Journal:  J Endovasc Ther       Date:  2011-08       Impact factor: 3.487

Review 6.  The innervation of the cranial dura mater: neurosurgical case correlates and a review of the literature.

Authors:  William J Kemp; R Shane Tubbs; Aaron A Cohen-Gadol
Journal:  World Neurosurg       Date:  2011-12-09       Impact factor: 2.104

7.  The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.

Authors:  D J Williamson; R G Hill; S L Shepheard; R J Hargreaves
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

8.  Steroids for migraine headaches: a randomized double-blind, two-armed, placebo-controlled trial.

Authors:  Frederick W Fiesseler; Richard Shih; Paul Szucs; Michael E Silverman; Barnet Eskin; Martin Clement; Rachna Saxena; John Allegra; Renee L Riggs; Nima Majlesi
Journal:  J Emerg Med       Date:  2009-10-21       Impact factor: 1.484

9.  Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache.

Authors:  Brian H Rowe; Ian Colman; Marcia L Edmonds; Sandra Blitz; Alan Walker; Sheldon Wiens
Journal:  Headache       Date:  2007-11-28       Impact factor: 5.887

10.  Low-dose propofol for the abortive treatment of pediatric migraine in the emergency department.

Authors:  David C Sheridan; David M Spiro; Thuan Nguyen; Thomas K Koch; Garth D Meckler
Journal:  Pediatr Emerg Care       Date:  2012-12       Impact factor: 1.454

View more
  1 in total

1.  Therapeutic Use of the Newly Described "Artery of Qureshi".

Authors:  Yousef Mohammad
Journal:  J Vasc Interv Neurol       Date:  2018-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.